MELANIE GRIFFITH: Open Payments
NPI 1538732797 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 76 payments from 13 companies in 2025. Trend: 2023 $1,440 · 2024 $1,416 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $361 |
| Ardelyx, Inc. | 11 | $249 |
| Janssen Biotech, Inc. | 10 | $187 |
| Ferring Pharmaceuticals Inc. | 5 | $105 |
| Aimmune Therapeutics, Inc. | 5 | $96 |
| PFIZER INC. | 3 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $47 |
Products named: IBSRELA, RINVOQ, TREMFYA, REBYOTA, ZENPEP, XIFAXAN, VELSIPITY, LINZESS.
Industry payments across TN — which companies pay providers there.
